A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
At Fred Hutch, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers — including three Nobel laureates — bring a relentless passion to their work and deliver hope to patients who come from all over the world. We’re discovering new ways to detect cancers earlier, when cure rates are highest; developing effective treatments with fewer side effects; and learning how to prevent cancers from developing in the first place.
Seattle, Washington Clinical Trial Location
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N,
Seattle, WA 98109